Related Experiment Videos
[Treatment of Wilson's disease with Zincteral]
A Kuczyńska-Zardzewiały1, M Rodo, A Członkowska
1Kliniki Chorób Naczyniowych Układu Nerwowego Instytutu Psychiatrii i Neurologii w Warszawie.
Neurologia I Neurochirurgia Polska
|May 1, 1988
Abstract:
In 27 patients with reliably diagnosed Wilson's disease treated previously with penicillamine (Cuprenil, Polfa) for from 10 months to 12 years penicillamine was withdrawn due to various adverse effects and replaced with zinc sulphate (Polish preparation Zincteral) in doses of 200 mg 4 times daily for 12 months. The neurological status was improved in 6 cases. No adverse effects of zinc sulphate were observed.